Logical Therapeutics is a development stage biotechnology company, with clinical and pre-clinical stage medicines to treat diseases that are associated with poorly controlled or excessive inflammation. Inflammation is a key component of the body's response to injury or infection. When it is properly regulated and controlled, inflammation is beneficial because it promotes the healing of wounds and participates in the defending the body against infection by pathogenic microbes. However, poorly controlled inflammation contributes to the pathogenesis of diseases such as rheumatoid arthritis and osteoarthritis. Additionally, it is increasingly apparent that chronic inflammation is also a factor in the development of a host of other chronic diseases, including diabetes mellitus, metabolic syndrome, certain digestive disorders, asthma, atherosclerotic heart disease and even cancer.

For more information, please visit